Back to search

Article

Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart Review

2023-09-03

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Introduction</h4> Antivirals with differing mechanisms of action are needed for COVID-19 treatment; remdesivir is mainly used in hospitalized patients, but additional antivirals are needed in this setting. Ensitrelvir, a 3C-like protease inhibitor, received emergency approval in Japan in November 2022, based on evidence of rapid symptom resolution in non-hospitalized patients, but confirmatio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
a53b64e1-7334-5049-b227-7eee8e51068b
DOI
10.1101/2023.09.03.23294865
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Ensitrelvir Fumaric Acid in Patients with SARS-CoV-2: A Retrospective Chart ReviewDOI 10.1101/2023.09.03.23294865
Recent updates on COVID-19: A holistic reviewSemantic proximity
Clinical and Epidemiological Data of COVID-19 from Regensburg, Germany – A Retrospective analysis of 1084 consecutive casesSemantic proximity
REGEN-COV Antibody Combination in Outpatients With COVID-19 – Phase 1/2 ResultsSemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
Effectiveness of Molnupiravir for the Treatment of COVID-19: A Systematic Literature Review of Real-World Observational StudiesSemantic proximity
REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 OutpatientsSemantic proximity
Current status and clinical outcomes of pharmacotherapies according to SARS-CoV-2 mutations in patients with mild-to-moderate COVID-19: a retrospective single center study.Semantic proximity
Sporadic Occurrence of Ensitrelvir-Resistant SARS-CoV-2, Japan.Semantic proximity
Real-world Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the United StatesSemantic proximity
Outcomes with and without outpatient SARS-CoV-2 treatment for patients with COVID-19 and systemic autoimmune rheumatic diseases: A retrospective cohort studySemantic proximity
Real World Evidence of the Neutralizing Monoclonal Antibody Sotrovimab for Preventing Hospitalization and Mortality in COVID-19 OutpatientsSemantic proximity
The Era of the Coronavirus Disease 2019 Pandemic: A Review on Dynamics, Clinical Symptoms and Complications, Diagnosis, and Treatment.Semantic proximity
Select a neighboring publication to make it the new centre.